Opportunities for therapeutic antibodies directed at G-protein

Por um escritor misterioso

Descrição

Opportunities for therapeutic antibodies directed at G-protein
Frontiers Accelerating GPCR Drug Discovery With Conformation
Opportunities for therapeutic antibodies directed at G-protein
Strategies for fibroblast targeted therapy. (A) Cell surface
Opportunities for therapeutic antibodies directed at G-protein
Covalently Engineered Nanobody Chimeras for Targeted Membrane
Opportunities for therapeutic antibodies directed at G-protein
Mechanisms of signalling and biased agonism in G protein-coupled
Opportunities for therapeutic antibodies directed at G-protein
GPCRs as Emerging ADC Drug Candidates - BioProcess
Opportunities for therapeutic antibodies directed at G-protein
GPCRs: How Do They Work and How Do We Study Them?
Opportunities for therapeutic antibodies directed at G-protein
Development of therapeutic antibodies for the treatment of
Opportunities for therapeutic antibodies directed at G-protein
Directed evolution of and structural insights into antibody
Opportunities for therapeutic antibodies directed at G-protein
Frontiers What Makes Antibodies Against G Protein-Coupled
Opportunities for therapeutic antibodies directed at G-protein
Direct Selection of DNA-Encoded Libraries for Biased Agonists of
Opportunities for therapeutic antibodies directed at G-protein
Frontiers What Makes Antibodies Against G Protein-Coupled
Opportunities for therapeutic antibodies directed at G-protein
Development of therapeutic antibodies for the treatment of
Opportunities for therapeutic antibodies directed at G-protein
Engineered Histidine‐Rich Peptides Enhance Endosomal Escape for
de por adulto (o preço varia de acordo com o tamanho do grupo)